Croner Roland S, Perrakis Aristotiles, Hohenberger Werner, Brunner Maximillian
Department of Surgery, Liver Center, University Hospital Erlangen, Krankenhausstrasse 12, 91054, Erlangen, Germany.
Langenbecks Arch Surg. 2016 Aug;401(5):707-14. doi: 10.1007/s00423-016-1440-1. Epub 2016 May 20.
Minimally invasive liver surgery is increasing worldwide. The benefit of the robot in this scenario is currently controversially discussed. We compared our robotic cases vs. laparoscopic and open minor hepatic resections and share the experience.
From 2011 to 2015, ten patients underwent robotic and 19 patients underwent laparoscopic minor liver resections in the Department of Surgery, University Hospital Erlangen. These patients were compared to a case-matched control group of 53 patients. The perioperative prospectively collected data were analyzed retrospectively.
Blood loss was significantly decreased in the robotic (306 ml) and laparoscopic (356 ml) vs. the open (903 ml) surgery group (p = 0.001). Mean tumor size was 4.1-4.8 cm in all groups (p = 0.571). Negative surgical margins were present in 94 % of the open and 100 % of the laparoscopic and robotic group (p = 0.882). Time for surgery was enlarged for robotic (321 min) vs. laparoscopic (242 min) and open (186 min) surgery (p = 0.001). Postoperative hospitalization was decreased after robotic (7 days) and laparoscopic (8 days) vs. open (10 days) surgery (p = 0.004). Total morbidity was 17 % for open, 16 % for laparoscopic, and 1 % for robotic cases (p = 0.345). Postoperative pain medication and elevation of liver enzymes were remarkably lower after minimally invasive vs. open procedures.
Minimally invasive liver surgery can be performed safely for minor hepatic resections and should be considered whenever possible. Minor liver resections can be performed by standard laparoscopy equivalent to robotic procedures. Nevertheless, the robot adds a technical upgrade which may have benefits for challenging cases and major liver surgery.
微创肝脏手术在全球范围内日益增多。目前,对于机器人在这种情况下的益处存在争议性讨论。我们比较了机器人手术病例与腹腔镜和开放性小肝切除术,并分享经验。
2011年至2015年期间,埃尔朗根大学医院外科有10例患者接受了机器人辅助小肝切除术,19例患者接受了腹腔镜小肝切除术。将这些患者与一个由53例患者组成的病例匹配对照组进行比较。对围手术期前瞻性收集的数据进行回顾性分析。
与开放性手术组(903毫升)相比,机器人手术组(306毫升)和腹腔镜手术组(356毫升)的失血量显著减少(p = 0.001)。所有组的平均肿瘤大小为4.1 - 4.8厘米(p = 0.571)。开放性手术组94%、腹腔镜手术组和机器人手术组100%实现了阴性手术切缘(p = 0.882)。机器人手术(321分钟)的手术时间比腹腔镜手术(242分钟)和开放性手术(186分钟)延长(p = 0.001)。机器人手术(7天)和腹腔镜手术(8天)后的术后住院时间比开放性手术(10天)缩短(p = 0.004)。开放性手术的总发病率为17%,腹腔镜手术为16%,机器人手术为1%(p = 0.345)。与开放性手术相比,微创手术后的术后疼痛药物使用和肝酶升高明显更低。
对于小肝切除术,微创肝脏手术可以安全进行,应尽可能予以考虑。小肝切除术可通过与机器人手术相当的标准腹腔镜手术进行。尽管如此,机器人增加了一项技术升级,这可能对具有挑战性的病例和大肝手术有益。